Daraxonrasib Resets Pancreatic Cancer Math; SoftBank Bets Big on French Compute; Palo Alto Bug Hits Live Networks
The dominant story is daraxonrasib, a pancreatic cancer pill whose phase 3 data put a hard number on a field…
-
-
Mistral Pushes On-Prem AI; MCP Settles Into Default Status; Zig Speeds The Edit Loop; AI Speeds Game Decompilation
The cleanest story today is Mistral on-prem AI. While the model race still gets the attention, the harder commercial signal…
-
ByteDance Eyes Inference Silicon; Cloudflare Automates First-Pass Reviews; SQLite Creeps Into Agent Runtime
ByteDance chips are the clearest signal today, even if the clearest fact is still that the company has not confirmed…
-
PostHog Defaults to Training; AI Reports Swamp Maintainers; Zero Days Go Public; Atomic Manufacturing Gets Evidence
The sharpest story today is PostHog customer data, because it spells out a trend vendors usually leave implied. Elsewhere, the…
-
Coding Models Hit Price-War Mode; Microsoft Pulls Back Claude Code; Dutch State Blocks DigiD Supplier Deal
The clearest signal today is not a new model benchmark, but AI coding economics getting less polite. Between DeepSeek’s 75%…
-
Builder.AI Mixed AI Software With Human Engineering, Then Collapsed Amid Fraud Allegations
Builder.ai did not simply “fake AI with 700 engineers in India”; it appears to have had both a real software…
